Abatacept treatment for patients with early active primary Sjögren’s syndrome: a single-centre, randomised, double-blind, placebo-controlled, phase 3 trial (ASAP-III study) - van Nimwegen, JF; Mossel, E; van Zuiden, GS (The Lancet Rheumatology, 2020)
et al.